Meretoja, Atte, Yassi, Nawaf, Wu, Teddy Y., Churilov, Leonid, Sibolt, Gerli, Jeng, Jiann-Shing, Kleinig, Timothy, Spratt, Neil J., Thijs, Vincent, Wijeratne, Tissa, Cho, Der-Yang, Shah, Darshan, Cloud, Geoffrey C., Phan, Thanh, Bladin, Christopher, Moey, Andrew, Aviv, Richard I., Barras, Christen D., Sharma, Gagan, Hsu, Chung Y., Levi, Christopher, Ma, Henry, Campbell, BCV, Mitchell, P, Yan, B, Parsons, MW, Tiainen, M, Curtze, S, Strbian, D, Tang, SC, Harvey, J, Donnan, GA, Davis, SM. The Lancet Publishing Group; 2020. Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial.

Yassi, Nawaf, Zhao, Henry, Jeng, Jiann-Shing, Choi, Philip M. C., Duc, Phuc Dang, Brown, Helen, Ranta, Annemarei, Spratt, Neil, Cloud, Geoffrey C., Wang, Hao-Kuang, Grimley, Rohan, Mahawish, Karim, Churilov, Leonid, Cho, Der-Yang, Shah, D, Nguyen, TMP, Sharma, G, Yogendrakumar, V, Yan, B, Harrison, EL, Devlin, M, Cordato, D, Martinez-Majander, N, Wu, Teddy Y., Strbian, D, Thijs, V, Sanders, LM, Anderson, D, Parsons, MW, Campbell, BCV, Donnan, GA, Davis, SM, Ma, Henry, Nguyen, Huy-Thang, Cheung, Andrew, Meretoja, Atte, Mai, Duy Ton, Kleinig, Timothy. The Lancet Publishing Group; 2024. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.